PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidate
Brand(s)
Last updated
Summary
Product
PMS-Methylphenidate CR 10 mg capsule
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot number |
|---|---|---|---|---|---|
| Pharmascience Inc. | PMS-Methylphenidate CR 10 mg capsule | DIN 02536943 | Capsule (extended release) | Methylphenidate hydrochloride 10 mg | 650529 |
Issue
The affected lot exceed the acceptable intake limit for N-nitroso-methylphenidate (NMPH).
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Pharmascience Inc.
100 6111 Royalmount Ave
Montreal Quebec H4P 2T4 Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-77672
Get notified
Receive notifications for new and updated recalls and alerts by category.